PAVmed (PAVM) Total Debt Growth (5y) (2022 - 2025)
PAVmed (PAVM) Total Debt Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn |
| 10 | PAVmed | 11.18 Mn | 9.64 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.27% |
| Sep 30, 2025 | 7.98% |
| Jun 30, 2025 | -24.92% |
| Mar 31, 2025 | -20.42% |
| Dec 31, 2024 | 12.32% |
| Jun 30, 2024 | 45.32% |
| Mar 31, 2024 | 40.73% |
| Dec 31, 2023 | 41.10% |
| Sep 30, 2023 | 69.08% |
| Jun 30, 2023 | 73.30% |
| Mar 31, 2023 | 81.49% |
| Dec 31, 2022 | 76.87% |
| Sep 30, 2022 | 86.28% |